New products
New products are an essential part of our range with many new small molecules and peptides being added every year. If you can't find what you are looking for we welcome new product suggestions.
If you would like to be kept informed about new products by email, please sign up to our mailing list.
2023
March
AM-380 Hc-CATH Cathelicidin from sea snake venom
AC-020 p16 GPR126 activator
AC-010 p13 GPR133 activator
RK-010 BMP2pp BMP-2 mimetic
February
PP-400 TAT-QFNP12 NDRG2 - PPM1A binding blocker
EP-040 EGFRvIII peptide EGFRvIII derived epitope
AM-370 D-K6L9 Antimicrobial and anticancer peptide
January
PP-390 BRC4wt Blocks BRCA2–RAD51 interaction
CK-040 CXCL9(74–103) Competes with CXCL8 for GAG binding
GT-010 KRpep-2d K-Ras inhibitor
DA-010 KEMPFPKYPVEP peptide Improves memory performance
2022
December
PN-220 LIH383 Atypical chemokine receptor (ACKR3) agonist
TL-010 SPA4 peptide TLR4 interacting peptide
NU-010 Neuromedin S (human) Endogenous neuromedin U receptor agonist
AV-020 VIRIP Endogenous HIV-1 inhibitor
EP-030 HOXB7 8–25 Targets HOXB7 expressing tumours
November
IG-060 VnP-16 β1 and αvβ3 integrin signaling modulator
AM-360 OP-145 Antimicrobial peptide derived from LL-37
HM-010 PTD2 WHSC1 inhibitor
October
PP-380 PD-L1Pep-2 Binds to PD-L1
PP-370 TAT-HuR-HNS3 HuR-PARP1 interaction blocker
KS-220 Tat-braftide Allosteric BRAF inhibitor
September
PP-360 SMRwt Disrupts the Nef-mortalin interaction, anti-metastatic
AM-350 Urumin Antiviral host defense peptide
CY-040 rytvela scrambled peptide Scrambled control peptide for rytvela
August
PP-350 PDHPS1 YAP signaling pathway inhibitor
AM-340 KLA peptide Proapoptotic mitochondrial membrane disruptor
RT-030 FGF7p FGF7 mimetic
July
TP-030 TIP TRPV1 inhibitor
PI-290 Multi-Leu peptide PACE4 inhibitor
PP-340 Tat-D3S2 DIRAS3 - beclin1 interaction inhibitor
June
PP-330 RS17 CD47 - SIRPα signalling inhibitor
KS-210 MOTS-c AMPK activator
PP-320 VGN50 Blocks MYC activation
May
PI-270 Compstatin C3 convertase inhibitor
PP-310 Rb4 Induces expression of HMGB1 and calreticulin
PI-280 Q14 USP30 inhibitor
April
CK-030 EPI-X4 Endogenous CXCR4 antagonist
HD-010 SAP15 HDAC5 inhibitor
PP-300 NP-12 PD-1/PD-L1 interaction blocker
March
PP-290 KP1 Disrupts TGF-β/TβR2 interaction
CY-030 rytvela IL-1 receptor allosteric antagonist
OR-030 SHBG141–161 GPRC6A agonist
PP-280 TPP-1 Blocks PD-1/PD-L1 interaction
February
IG-050 Synstatin Syndecan-1 mediated integrin activation inhibitor
NR-180 S9pep SOX9 mimetic
PP-270 TAT-ANK Dll4-Notch1 inhibitor
January
CH-010 Chemerin-9 Chemokine-like receptor 1 (CMKLR1) agonist
PP-260 Tat-NTS peptide Blocks the interaction of ANXA1 with importin β
AS-010 NT1–20 Blocks ASIC1a binding to RIPK1
2021
December
TP-020 SOR-C13 TRPV6 antagonist
AM-330 AMPR-22 Antimicrobial peptide derived from Romo1
FZ-010 Fz7-21 Selective FZD7 antagonist
CY-020 S7 Interleukin-6 inhibitor
November
PR-100 P4pal10 PAR4 antagonist
TP-010 tatM2NX Cell permeable TRPM2 antagonist
CK-020 HBP08 CXCL12/HMGB1 heterocomplex inhibitor
EP-020 SFKEELDKYFKNHTSP Epitope from the S2 protein of SARS-CoV-2
FP-030 Atto647N-LPETGG Sortase reagent
October
FP-040 Atto550-LPETGG Sortase reagent
PP-250 A11 ANXA1–EphA2 interaction blocker
AV-010 F9170 Inactivates HIV-1 virions
PP-240 NFAT Inhibitor Calcineurin-NFAT interaction inhibitor
September
PP-230 Tat-CIRP MD2 - CIRP interaction blocker
CR-020 CRF (human, rat) Endogenous CRF receptor agonist
SP-050 Rad17 derived peptide ATR kinase substrate
OX-050 Orexin A (human, rat, mouse) OX1 and OX2 receptor agonist
OR-020 VPM-p15 GPR64 (ADGRG2) agonist
CY-010 S1H Human growth hormone receptor antagonist
PP-220 F1 Blocks the association of IKKbeta and NEMO
August
PP-210 p28 Binds to p53 and inhibits cop1 binding
GL-040 GIP_HUMAN[22–51] Endogenous proatherosclerotic peptide hormone
AM-320 IDR 1002 Innate defence regulator peptide
PP-200 Tat-beclin 1 Autophagy inducing peptide
AM-310 Pexiganan Broad spectrum antibacterial agent
July
PP-170 Caveolin-1 scaffolding domain peptide The binding domain of caveolin-1
PP-120 (D)-PPA 1 PD-1/PD-L1 interaction inhibitor
PP-040 Tat-βsyn-degron α-Synuclein knockdown peptide
PP-110 Foxy 5 Wnt5a mimetic peptide
PP-030 KSL 128114 Binds the PDZ1 domain of syntenin
June
AM-300 SAAP 148 Antimicrobial peptide derived from LL-37
AM-290 Pap12-6 Antibacterial derived from the N-terminus of papiliocin
AM-280 BING Antimicrobial peptide from Japanese medaka fish
Learn more
Contact Information
To place an order, or for customer services, order processing or technical support please contact us on:
UK, Europe and RoW
Tel: (+44) 01392 422205Fax: (+44) 01392 279510
info@iscabiochemicals.com
USA and Canada
Tel: 610-994-1134
Toll Free: 855-FOCUS21 (855-362-8721)
Fax: 610-465-9100
France
CliniSciences
Tel : +33 9 77 40 09 09
Fax : +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com
Germany, Switzerland, Austria
BIOZOL Diagnostics
Tel: +49 (089) 3799 666-6
Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de
Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com
Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80
Fax: +34 94 404 80 81
Orders: info@abyntek.com
BIOHUB INTERNATIONAL
上海起发实验试剂有限公司
Tel: +86-15921799099
Tel: +86-021-50724187
Fax: +86-021-50724961
Orders: sale3@78bio.com
India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com
Japan
Namiki Shoji Co.
Tel:+81-050-5527-9850
Fax:+81-3-3352-2196
email: globalbusiness1@namiki-s.co.jp